Page last updated: 2024-11-07

penicillamine and Abnormalities, Congenital

penicillamine has been researched along with Abnormalities, Congenital in 2 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Research Excerpts

ExcerptRelevanceReference
"Untreated Wilson's disease usually causes infertility or abortion, as a result of increased intrauterine copper level."1.27[Teratogenic risk during treatment of Wilson disease]. ( Mathieu, M; Piussan, C, 1985)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carey, JC1
Martinez, L1
Balken, E1
Leen-Mitchell, M1
Robertson, J1
Piussan, C1
Mathieu, M1

Reviews

1 review available for penicillamine and Abnormalities, Congenital

ArticleYear
Determination of human teratogenicity by the astute clinician method: review of illustrative agents and a proposal of guidelines.
    Birth defects research. Part A, Clinical and molecular teratology, 2009, Volume: 85, Issue:1

    Topics: Abnormalities, Drug-Induced; Antifungal Agents; Antirheumatic Agents; Congenital Abnormalities; Evid

2009

Other Studies

1 other study available for penicillamine and Abnormalities, Congenital

ArticleYear
[Teratogenic risk during treatment of Wilson disease].
    Journal de genetique humaine, 1985, Volume: 33, Issue:3-4

    Topics: Adult; Congenital Abnormalities; Copper; Female; Fetus; Hepatolenticular Degeneration; Humans; Infan

1985